Company Search:
Advanced Search
Sponsored Links
Cambrex Corporation Company Snapshot
Cambrex Corporation operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cambrex with three other companies in this sector in the United States: Emergent BioSolutions, Inc. (2016 sales of $488.78 million ), Swedish Orphan Biovitrum AB (publ) ($524.18 million of which 41% was Haemophilia: Elocta), and DepoMed, Inc. ($455.90 million of which 100% was Product research reve).

Sales Analysis. Cambrex reported sales of $490.34 million for the year ending December of 2016. This represents an increase of 13.0% versus 2015, when the company's sales were $433.93 million. Sales at Cambrex have increased during each of the previous five years (and since 2011, sales have increased a total of 92%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Cambrex Corporation
  Stock Performance Chart for Cambrex Corporation
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 51.65
(Figures in U.S. Dollars)
1 Week 1.9%   13 Weeks 2.4%  
4 Weeks -3.8%   52 Weeks -7.5%  
Cambrex Corporation Key Data:
  Ticker: CBM Country: United States
  Exchanges: NYSE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 490,338,000
(Year Ending Jan 2017).
Employees: 1,295
  Currency: U.S. Dollars Market Cap: 1,692,755,200
  Fiscal Yr Ends: December Shares Outstanding: 32,773,576
  Share Type: Common Closely Held Shares: 430,775
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.